Pure Biologics achieves key milestone with successful completion of Phase 0 study for PBA-0405 in cancer treatment
26 February
2025

Pure Biologics achieves key milestone with successful completion of Phase 0 study for PBA-0405 in cancer treatment

Pure Biologics today announced the successful completion of its Phase 0 clinical study for the novel cancer therapy, PBA-0405.
Read more
News
Inquiries
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers